J&J Vision announces availability of TECNIS Synergy IOL

Company introduces 'revolutionary' continuous-range-of-vision IOL

J&J Vision announces availability of TECNIS Synergy IOL
Priscilla Lynch
Priscilla Lynch
Published: Sunday, September 15, 2019
JOHNSON & Johnson Vision (JJV) invites ESCRS delegates to look at what the company describes as its “revolutionary” continuous-range-of-vision intraocular lens for patients with cataracts, which is now available in Europe, Australia and New Zealand. “TECNIS Synergy™ IOL creates a new standard in presbyopia-correcting IOL technology, allowing patients to experience continuous high-contrast vision from far through near, even in low-light conditions,” a company spokesperson said. “With TECNIS Synergy IOL, we have created our most advanced IOL solution yet, which gives patients the clear, continuous range of vision they want, day and night,” said Tom Frinzi, Worldwide President, Surgical, Johnson & Johnson Vision. “As ophthalmic pioneers, we continue to challenge ourselves on a daily basis to create solutions to the ever-changing needs of patients. Today, we stay true to our legacy of innovation with the introduction of TECNIS Synergy IOL, which we believe will redefine the industry standard for IOL quality and performance.” Visit the JJV booth to learn more – Pavilion 7, Floor 7.2 Booth #E112
Tags: intraocular lens
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...